Le JDB : Le point d'actu avec Frédéric Gomez (Pharmium Securities)

from Le Journal des Biotechs · host BOURSORAMA

Dans ce premier numéro de l'année du Journal des biotechs, Frédéric Gomez, analyste chez Pharmium Securities, revient sur les grosses news tombées fin 2021 sur Genfit et DBV Technologies et nous explique ce qu'il faut attendre dans les mois qui viennent.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published Jan 6, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Le JDB : Le point d'actu avec Frédéric Gomez (Pharmium Securities)

0:00 13:05

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 13 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on January 6, 2022.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!